Defilade Capital Management »

Biogen Idec shares owned by Defilade Capital Management

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Defilade Capital Management from 13F filings

Historical chart of Defilade Capital Management investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Defilade Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Defilade Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $18M 96k 183.33

More positions owned by Defilade Capital Management

Zimmer Holdings (ZBH)
Henry Schein (HSIC)
Becton, Dickinson and (BDX)
Pfizer (PFE)
Dex (DXCM)
ICU Medical, Incorporated (ICUI)
Insmed Com Par $.01 (INSM)
Intuitive Surgical Com New (ISRG)
Revolution Medicines (RVMD)
Globus Med Cl A (GMED)
Neurocrine Biosciences (NBIX)
Denali Therapeutics (DNLI)
Ptc Therapeutics I (PTCT)
Olema Pharmaceuticals (OLMA)
Elanco Animal Health (ELAN)

View all positions for Defilade Capital Management

Top funds holding Biogen Idec

Vanguard Group
BlackRock
PRIMECAP Management Company
Vanguard Capital Management
FMR
State Street Corporation
Vanguard Portfolio Management
Geode Capital Management
Wellington Management Company
Susquehanna International
Morgan Stanley
AQR Capital Management
Invesco
Robeco Investment Management
Barclays

View all funds holding Biogen Idec